Subjects,Age range(y),Etiology,Time to MRI (d),CRS-R score,CRS-R subscore
Patient 1,26–30,TBI,102,7 (MCS),113002
,,,311,23 (EMCS),456323
Patient 2,16–20,TBI,28,7 (MCS),113002
,,,83,23 (EMCS),456323
Patient 3,11–15,TBI,72,1 (UWS),001000
,,,404,22 (EMCS),456313
Patient 4,26–30,TBI,47,2 (UWS),000002
,,,92,14 (MCS),345002
,,,450,23 (EMCS),456323
Patient 5,46–50,Anoxia,28,4 (UWS),011002
,,,117,7 (UWS),112102
Patient 6,46–50,TBI,81,6 (UWS),112002
,,,173,7 (UWS),112102
Patient 7,46–50,TBI,32,5 (UWS),102002
,,,140,6 (UWS),112002
Patient 8,41–45,Anoxia,28,4 (UWS),101002
,,,54,4 (UWS),101002
Patient 9,51–55,TBI,67,5 (UWS),111002
,,,93,11 (MCS),233102
Control 1,26–30,/,/,/,/
Control 2,21–25,/,/,/,/
Control 3,26–30,/,/,/,/
Control 4,16–20,/,/,/,/
Control 5,51–55,/,/,/,/
Control 6,61–65,/,/,/,/
Control 7,56–60,/,/,/,/
Control 8,66–70,/,/,/,/
Control 9,51–55,/,/,/,/
Control 10,61–65,/,/,/,/
Control 11,56–60,/,/,/,/
